Mark the dates!
12 December 2011 | News
India BIO 2012 - Bangalore
The 12th edition of Bangalore India BIO will be held on February 6-8, 2012 in Bangalore. This three day event aims to focus on areas that are essential to make India a strong bioeconomy. The event will consist of a multi-track conference, international trade show, BioPartnering India, vision leadership series, CEO conclave (featuring a panel discussion between top CEO's), a poster session 'Walkway of Discovery', BioQuiz for biotechnology students along with Bio-excellence Awards for companies and individuals.
BioPartnering India, one of the key features of Bangalore India BIO, offers a unique platform for delegates to scout for partnering opportunities with the global biotech community. The BioPartnering India initiative in 2011 received phenomenal response with over 530 business meetings facilitated. It will also discuss issues such as collaborative and integrative business models as well as policy, regulation, and investment challenges for biotechnology in a global bioeconomy and will provide networking and knowledge sharing platform for business leaders, policy makers, research heads and academia.
BioAsia 2012 - Hyderabad
The ninth edition of BioAsia, with the theme of 'Optimizing Opportunities', will be held from February 9 to 11, 2012, at Hyderabad. It will focus on CROs, IPR, vaccines and investments. The event promises to be the door to opportunities with the participation of a dynamic mix of high profile industry thought leaders, policy makers and other key stakeholders of the industry. BioAsia has also gone a step further to augment the global event through a basket of satellite event offerings, such as BioBazaar, BioPartnering, CEO conclaves, tradeshow, policy discussions, conferences and more.
At the curtain raiser of the event, held in Hyderabad, Dr KV Raghavan, vice president of Federation of Asian Biotech Associations and former director, Indian Institute of Chemical Technology, said that representatives of the top 16 MNCs in bio-pharma arena have confirmed their participation. A state-of-the-art partnering system which integrates professional and social networking platforms will also be part of this prestigious event.
Mr Shakthi Nagappan, CEO of BioAsia 2012, announced the list of partners for BioAsia 2012, which includes Frost & Sullivan, Confederation of Indian Industries, Institute of Life Sciences, Alexandria Equities Management, Lonza India, Hyde Engineering & Consulting and Yes Bank, among others. Further, the organizers announced the support from various parts of the globe through regional industry associations like SwedenBIO, Swiss Biotech, AusBiotech, Biocat (Spain) and European Federation of Biotechnology among others.
BioAsia 2012 has already attracted high profile speakers and global thought leaders like Dr Richard Connell, vice president and head of R&D, Pfizer, Shanghai; Dr Ajit Shetty, president, Johnson & Johnson, Dr Hasit Joshipura, VP and MD, GSK; Mr Pankaj Patel, chairman, Zydus Cadila; Dr N K Ganguly, chairman, Immunology Foundation and former director general, Indian Council for Medical Research; Dr Suresh Jadhav of Serum Institute of India; Dr Darren JI, CEO, PharmaLegacy Labs, China; Dr Cyrus Karkaria, president Biotech, Lupin (India), among others.
The 12th edition of Bangalore India BIO will be held on February 6-8, 2012 in Bangalore. This three day event aims to focus on areas that are essential to make India a strong bioeconomy. The event will consist of a multi-track conference, international trade show, BioPartnering India, vision leadership series, CEO conclave (featuring a panel discussion between top CEO's), a poster session 'Walkway of Discovery', BioQuiz for biotechnology students along with Bio-excellence Awards for companies and individuals.
BioPartnering India, one of the key features of Bangalore India BIO, offers a unique platform for delegates to scout for partnering opportunities with the global biotech community. The BioPartnering India initiative in 2011 received phenomenal response with over 530 business meetings facilitated. It will also discuss issues such as collaborative and integrative business models as well as policy, regulation, and investment challenges for biotechnology in a global bioeconomy and will provide networking and knowledge sharing platform for business leaders, policy makers, research heads and academia.
BioAsia 2012 - Hyderabad
The ninth edition of BioAsia, with the theme of 'Optimizing Opportunities', will be held from February 9 to 11, 2012, at Hyderabad. It will focus on CROs, IPR, vaccines and investments. The event promises to be the door to opportunities with the participation of a dynamic mix of high profile industry thought leaders, policy makers and other key stakeholders of the industry. BioAsia has also gone a step further to augment the global event through a basket of satellite event offerings, such as BioBazaar, BioPartnering, CEO conclaves, tradeshow, policy discussions, conferences and more.
At the curtain raiser of the event, held in Hyderabad, Dr KV Raghavan, vice president of Federation of Asian Biotech Associations and former director, Indian Institute of Chemical Technology, said that representatives of the top 16 MNCs in bio-pharma arena have confirmed their participation. A state-of-the-art partnering system which integrates professional and social networking platforms will also be part of this prestigious event.
Mr Shakthi Nagappan, CEO of BioAsia 2012, announced the list of partners for BioAsia 2012, which includes Frost & Sullivan, Confederation of Indian Industries, Institute of Life Sciences, Alexandria Equities Management, Lonza India, Hyde Engineering & Consulting and Yes Bank, among others. Further, the organizers announced the support from various parts of the globe through regional industry associations like SwedenBIO, Swiss Biotech, AusBiotech, Biocat (Spain) and European Federation of Biotechnology among others.
BioAsia 2012 has already attracted high profile speakers and global thought leaders like Dr Richard Connell, vice president and head of R&D, Pfizer, Shanghai; Dr Ajit Shetty, president, Johnson & Johnson, Dr Hasit Joshipura, VP and MD, GSK; Mr Pankaj Patel, chairman, Zydus Cadila; Dr N K Ganguly, chairman, Immunology Foundation and former director general, Indian Council for Medical Research; Dr Suresh Jadhav of Serum Institute of India; Dr Darren JI, CEO, PharmaLegacy Labs, China; Dr Cyrus Karkaria, president Biotech, Lupin (India), among others.
